Partial response of metastatic melanoma to BRAF-inhibitor-monotherapy in a pregnant patient with no fetal toxicity.

Marcé, Diane

Partial response of metastatic melanoma to BRAF-inhibitor-monotherapy in a pregnant patient with no fetal toxicity. [electronic resource] - Melanoma research 08 2019 - 446-447 p. digital

Publication Type: Journal Article

1473-5636

10.1097/CMR.0000000000000600 doi


Adult
Female
Humans
Melanoma--drug therapy
Pregnancy
Protein Kinase Inhibitors--pharmacology
Skin Neoplasms--drug therapy
Vemurafenib--pharmacology